LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about MeiraGTx

Similar companies to MeiraGTx

MeiraGTx Tech Stack

MeiraGTx uses 8 technology products and services including Cloudflare, Microsoft Excel, Microsoft 365, and more. Explore MeiraGTx's tech stack below.

  • Cloudflare
    Content Management System
  • Microsoft Excel
    Editors
  • Microsoft 365
    Email
  • Backbone.js
    Javascript Frameworks
  • Windows Server
    Operating Systems
  • Microsoft Teams
    Team Collaboration
  • Animate.css
    UI Frameworks
  • Zoom
    Web Conferencing

Media & News

MeiraGTx's Email Address Formats

MeiraGTx uses at least 1 format(s):
MeiraGTx Email FormatsExamplePercentage
First.Last@meiragtx.comJohn.Doe@meiragtx.com
79%
First@meiragtx.comJohn@meiragtx.com
19%
First.L@meiragtx.comJohn.D@meiragtx.com
1%
Fir.Last@meiragtx.comJoh.Doe@meiragtx.com
1%

Frequently Asked Questions

Where is MeiraGTx's headquarters located?

Minus sign iconPlus sign icon
MeiraGTx's main headquarters is located at 92 Brittania Walk London/New York, N17NQ GB. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is MeiraGTx's phone number?

Minus sign iconPlus sign icon
You can contact MeiraGTx's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MeiraGTx's stock symbol?

Minus sign iconPlus sign icon
MeiraGTx is a publicly traded company; the company's stock symbol is MGTX.

What is MeiraGTx's official website and social media links?

Minus sign iconPlus sign icon
MeiraGTx's official website is meiragtx.com and has social profiles on LinkedIn.

How much revenue does MeiraGTx generate?

Minus sign iconPlus sign icon
As of September 2024, MeiraGTx's annual revenue reached $35M.

What is MeiraGTx's SIC code NAICS code?

Minus sign iconPlus sign icon
MeiraGTx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MeiraGTx have currently?

Minus sign iconPlus sign icon
As of September 2024, MeiraGTx has approximately 381 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Medical Officer: R. Z.Chief Operating Officer: R. G.Vice President Preclinical Development: T. G.. Explore MeiraGTx's employee directory with LeadIQ.

What industry does MeiraGTx belong to?

Minus sign iconPlus sign icon
MeiraGTx operates in the Biotechnology Research industry.

What technology does MeiraGTx use?

Minus sign iconPlus sign icon
MeiraGTx's tech stack includes CloudflareMicrosoft ExcelMicrosoft 365Backbone.jsWindows ServerMicrosoft TeamsAnimate.cssZoom.

What is MeiraGTx's email format?

Minus sign iconPlus sign icon
MeiraGTx's email format typically follows the pattern of . Find more MeiraGTx email formats with LeadIQ.

How much funding has MeiraGTx raised to date?

Minus sign iconPlus sign icon
As of September 2024, MeiraGTx has raised $50M in funding. The last funding round occurred on Aug 12, 2024 for $50M.

When was MeiraGTx founded?

Minus sign iconPlus sign icon
MeiraGTx was founded in 2015.
MeiraGTx

MeiraGTx

Biotechnology ResearchLondon/New York, United Kingdom201-500 Employees

MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage genetic medicine company with a broad pipeline of late-stage clinical programs supported by end-to-end manufacturing capabilities. MeiraGTx has an internally developed manufacturing platform process, internal plasmid production for GMP, two GMP viral vector production facilities as well as an in-house Quality Control hub for stability and release, all fit for IND through commercial supply. MeiraGTx has core capabilities in viral vector design and optimization and a potentially transformative riboswitch gene regulation platform technology that allows for the precise, dose-responsive control of gene expression by oral small molecules. MeiraGTx is focusing the riboswitch platform on delivery of metabolic peptides including GLP-1, GIP, Glucagon and PYY using oral small molecules, as well as cell therapy for oncology and autoimmune diseases. Although initially focusing on the eye, central nervous system, and salivary gland, MeiraGTx has developed the technology to apply genetic medicine to more common diseases, increasing efficacy, addressing novel targets, and expanding access in some of the largest disease areas where the unmet need remains great.

Section iconCompany Overview

Headquarters
92 Brittania Walk London/New York, N17NQ GB
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
MGTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
201-500

Section iconFunding & Financials

  • $50M

    MeiraGTx has raised a total of $50M of funding over 5 rounds. Their latest funding round was raised on Aug 12, 2024 in the amount of $50M.

  • $10M$50M

    MeiraGTx's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $50M

    MeiraGTx has raised a total of $50M of funding over 5 rounds. Their latest funding round was raised on Aug 12, 2024 in the amount of $50M.

  • $10M$50M

    MeiraGTx's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.